New diagnostic and therapeutic tools combining nanotechnology have been developed in recent medical research, which are beneficial to the specific transport and absorption of drugs and contrast agents to the brain, as well as promoting the regeneration of damaged neurons to limit or reverse neurological disorders. As a common neurological condition, dementia affected 46.8 million individuals globally in 2015, with that figure expected to rise to 131.5 million by 2050. Early identification is critical for efficient treatment of AD since neuro invasiveness and degenerative changes begin before the onset of symptoms. To detect and identify amyloid plaques, most investigations use magnetic resonance imaging (MRI) using contrast-doped NPs or tagging NPs with fluorescent probes. To combat neurodegenerative disorders, nanotechnology can be applied into neuroscience.
Title : Cerebral vascular calcium signaling in diabetic alzheimer's disease-related dementias
Yong Xiao Wang, Albany Medical College, United States
Title : Development of imaging based biomarkers for neurovascular abnormalities in neurodegenerative diseases
Jun Hua, Johns Hopkins University School of Medicine, United States
Title : Deep learning-based risk assessment of cognitive impairment using health examination data
Kaoru Sakatani, The University of Tokyo, Japan
Title : Him, that person and me
Simon C Barton, Stroke Survivor, United States
Title : Evaluation of the neuroprotective potential of indicaxanthin from opuntia ficus indica fruit against dysmetabolism-related neurodegeneration both in vivo and in vitro
Mario Allegra, University of Palermo, Italy
Title : Psychosocial considerations in management of corticobasal degeneration
Esraa Askar, Forest Hills Hospital, United States